Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10298227 | European Neuropsychopharmacology | 2005 | 6 Pages |
Abstract
Schizophrenia (SCZ) is a severe neuropsychiatric disorder with a genetic component. The major inhibitory GABA-(gamma-aminobutyric acid) ergic system may be involved. The GABA type B receptor 1 (GABBR1) gene has been localized to 6p21.3, a region linked to SCZ. We therefore investigated five polymorphisms (A-7265G, C10497G, Ser-491-Ser-T1473C, Phe-659-Phe-T1977C, and 3â²-UTR A33795G substitutions) in the GABBR1 gene in a sample of 101 DSM-IV SCZ probands and their families, 150 unrelated affected individuals matched with 150 healthy controls, using the transmission disequilibrium test (TDT) and case-control analysis. We did not observe biased transmission of alleles in any of the polymorphisms individually and haplotypes within the gene to SCZ probands. However, a weak significant difference was observed in the A-7265G polymorphism between the allelic frequency (Ï2=4.310, P=0.038) and a trend was observed between the genotype frequency (Ï2=4.970, 2 df, P=0.083) of SCZ individuals and controls. Further investigations of the role of GABBR1 in SCZ are warranted.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Gwyneth Zai, Nicole King, Gregory W.H. Wong, Cathy L. Barr, James L. Kennedy,